drugset / Trial / NCT05261750
Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and potential of dendritic cells therapy and secretomes therapy for advanced nasopharyngeal cancer.
Timeline
- Start
- 2022-04-30
- Primary completion
- 2026-02-28
- Completion
- 2026-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allo-DC-Secretome | Unknown | 2 ml | Intramuscular |
| Subject | Auto DC | Unknown | — | Intramuscular |